Lapides Asset Management’s Dentsply Sirona XRAY Stock Holding History

Lapides Asset Management’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$5.11M	Sell	127,600 -37,900	-23%	-$1.51M	3.34%	8
2023 Q1	$6.5M	Sell	165,500 -49,700	-23%	-$1.82M	3.94%	4
2022 Q4	$6.85M	Buy	215,200 +78,300	+57%	+$2.36M	3.65%	7
2022 Q3	$3.88M	Buy	136,900 +38,700	+39%	+$1.32M	2.21%	23
2022 Q2	$3.51M	Buy	98,200 +49,800	+103%	+$2.01M	1.75%	27
2022 Q1	$2.38M	Hold	48,400	–	–	1.04%	38
2021 Q4	$2.7M	Hold	48,400	–	–	1.18%	34
2021 Q3	$2.81M	Hold	48,400	–	–	1.16%	37
2021 Q2	$3.06M	Sell	48,400 -5,400	-10%	-$356K	1.22%	36
2021 Q1	$3.43M	Sell	53,800 -7,700	-13%	-$447K	1.44%	32
2020 Q4	$3.22M	Sell	61,500 -12,300	-17%	-$607K	1.38%	30
2020 Q3	$3.23M	Hold	73,800	–	–	1.77%	21
2020 Q2	$3.25M	Hold	73,800	–	–	1.88%	20
2020 Q1	$2.87M	Buy	73,800 +5,800	+9%	+$296K	2.16%	18
2019 Q4	$3.85M	Sell	68,000 -4,300	-6%	-$240K	2.01%	19
2019 Q3	$3.85M	Sell	72,300 -12,300	-15%	-$661K	1.99%	19
2019 Q2	$4.94M	Sell	84,600 -19,700	-19%	-$1.06M	2.28%	15
2019 Q1	$5.17M	Sell	104,300 -19,900	-16%	-$876K	1.95%	16
2018 Q4	$4.62M	Sell	124,200 -50,300	-29%	-$1.83M	1.87%	19
2018 Q3	$6.59M	Buy	+174,500	New	+$7.27M	1.44%	27

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lapides Asset Management's XRAY Position: Q2 2023 in Review

Lapides Asset Management reduced its Dentsply Sirona (XRAY) stake by 23% in Q2 2023, selling an estimated $1.51M and leaving 127,600 shares worth $5.11M. The position accounts for 3.34% of the portfolio, ranked #8.

Lapides Asset Management first reported a position in XRAY in Q3 2018 and has held it in 20 quarters since. The position peaked at $6.85M in Q4 2022. 471 funds tracked by Wall St. Rank hold XRAY as of Q2 2023.

Lapides Asset Management held 127,600 shares of Dentsply Sirona worth $5.11M as of Q2 2023.
Lapides Asset Management sold 37,900 Dentsply Sirona shares in Q2 2023, an estimated $1.51M.
Dentsply Sirona made up 3.34% of Lapides Asset Management's portfolio in Q2 2023, its #8 holding.
Lapides Asset Management first reported a position in Dentsply Sirona in Q3 2018 and has held it in 20 quarters since.
Lapides Asset Management's Dentsply Sirona position peaked at $6.85M in Q4 2022.
471 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2023.

Based on Lapides Asset Management's 13F filing for Q2 2023, filed 4 Aug 2023.